OFFICE OF RESEARCH AND SPONSORED PROGRAMS

OFFICE OF RESEARCH AND SPONSORED PROGRAMS
Monthly Summary of Grants and Contract Activity
May 2014
Corporate
Federal
Federal Flow-Down
Foundation/Other Non-Profit
1
28
23
14
4
3,916,511
9,855,291
1,215,649
180,520
69
$ 15,167,971
May 2014
Medical University of South Carolina
Printed: Jun 12, 2014
PROPOSALS
Submitted since July 2013
DEPARTMENT
College/Unit and Department
Administration
Academic Affairs/Provost
Assoc. Provost for Research
Information Services
Library Science and Informatics
Physical Plant
Risk Management
SC AHEC
VP for Finance and Administration
College of Dental Medicine
Oral Health Sciences
Pediatric Dentistry and Orthodontics
Stomatology
College of Graduate Studies
Graduate Studies
College of Health Professions
Health Professions
Health Sciences and Research
Health Studies
Healthcare Leadership & Management
College of Medicine
Anesthesia and Perioperative Medicine
Biochemistry and Molecular Biology
Cell and Molecular Pharmacology
Comparative Medicine
Deans Office - COM
Dermatology
Family Medicine
Medicine
Microbiology and Immunology
Neurology Reseach
Neurosciences
Neurosurgery Research
Obstetrics and Gynecology
Ophthalmology
Orthopaedic Surgery
Otolaryngology
Pathology and Laboratory Medicine
Pediatrics
Psychiatry and Behavioral Sciences
Public Health Sciences
Radiation Oncology
Radiology
Regenerative Medicine and Cell Biology
Surgery
Urology
College of Nursing
Nursing
Current
Month YTD
COLLEGE/UNIT
Current
Total Month YTD
0
0
0
0
0
0
0
1
2
18
1
18
1
1
3
1
130,687
991,419
920,000
2,171,673
250
3,000,000
2,087,914
242
4
0
0
22
2
3
4,513,034
34,850
114,917
1
1
42,361
1
0
0
0
11
28
1
2
1,620,022
9,392,504
1,913,063
279,450
0
6
10
1
0
0
1
35
6
5
9
4
2
4
0
6
6
15
21
8
2
4
3
3
2
1
38
43
7
6
1
7
323
97
31
160
11
17
32
10
35
59
128
195
63
7
48
58
60
14
368,750
10,241,755
12,065,986
716,797
6,852,142
210,597
2,496,456
62,916,573
19,321,602
4,623,293
29,747,873
449,315
2,834,769
7,469,771
4,215,535
3,985,162
10,412,122
14,436,457
46,186,212
13,351,563
1,486,605
5,217,023
11,191,511
10,133,423
1,946,311
6
2
45
Total
1
45
9,302,185
4
27
4,662,801
1
1
42,361
1
42
13,205,039
153
1451
282,877,603
6
45
8,555,026
8,555,026
May 2014
Medical University of South Carolina
Printed: Jun 12, 2014
PROPOSALS
Submitted since July 2013
DEPARTMENT
College/Unit and Department
College of Pharmacy
Drug Discovery & Biomedical Sciences
Pharmacy and Clinical Sciences
Current
Month YTD
COLLEGE/UNIT
Current
Total Month YTD
3
3
37
7,648,715
0
2
123,175
Total Proposals Submitted:
3
169
39
Total
7,771,890
1,650 326,416,905
May 2014
Medical University of South Carolina
Printed: Jun 12, 2014
AWARD ACTIVITY
LISTED BY FUNDING AGENCY
# Awards
Direct Costs
Total Costs
1
1
1
1
1
1
1
1
1
1
1
1
2
1
1
2
1
1
1
1
1
1
1
1
2
28
1,084
116,812
40,134
72,577
37,507
445,902
94,858
29,615
283,315
161,403
61,695
6,438
137,735
501,885
25,000
315,881
106,996
48,191
102,587
163,031
28,000
175,938
55,931
462
41,792
3,054,769
1,355
150,956
60,000
93,000
56,073
578,473
118,572
38,500
340,410
208,474
76,025
8,370
176,955
651,250
25,000
406,760
138,795
62,348
132,388
211,040
28,000
227,820
71,960
577
53,410
3,916,511
1
1
7
1
0
1
1
5
1
2
3
23
86,760
2,364,857
821,925
125,000
41,487
50,000
220,797
1,535,522
745,806
694,286
783,018
7,469,458
125,748
2,888,812
1,202,079
186,875
61,194
74,750
299,574
2,098,459
1,097,689
893,493
926,618
9,855,291
1
1
1
1
2
1
1
1
1
1
22,073
34,638
95,557
230,764
1,234
5,200
80,105
5,119
8,200
102,330
32,557
51,783
142,858
344,992
1,580
5,200
90,828
7,551
12,259
128,233
Corporate
AVEO Pharmaceuticals, Inc.
Astellas Pharma US, Inc.
Astrazeneca
Avedro Inc.
Berg, LLC
Biosense Webster, Inc.
Celator Pharmaceuticals, Inc.
Childrens Hosp. of Philadelphia
Cook, Inc.
Duke Univ.
Genentech, Inc.
INC Research, Inc.
INNO Clinical Outcomes, LLC
InfraReDx, Inc.
Multiple Sponsors
Novartis Corp.
PRA International
Portola Pharmaceuticals, Inc.
Quintiles Pacific, Inc.
SCRI Development Innovations, LLC
Siemens Medical Solutions USA
Taris Biomedical, Inc.
The Medicines Co.
Univ. of California, Los Angeles
W.L. Gore and Associates, Inc.
Federal
DOD
NIH/NCATS
NIH/NCI
NIH/NIA
NIH/NIAAA
NIH/NIAMS
NIH/NICHD
NIH/NIDA
NIH/NIGMS
NIH/NIMH
NIH/NINDS
Federal Flow-Down
Allegheny-Singer Research Inst.
Beth Israel Deaconess Med. Ctr.
Clemson Univ.
Mt. Sinai School of Medicine
New England Research Institutes
SC Sea Grant Consortium
SCUREF
Temple University
Univ. of Nebraska
Univ. of Pennsylvania
4
May 2014
Medical University of South Carolina
Printed: Jun 12, 2014
AWARD ACTIVITY
LISTED BY FUNDING AGENCY
# Awards
Direct Costs
Total Costs
1
2
14
11,217
258,483
854,920
16,545
381,263
1,215,649
1
1
1
1
4
5,020
100,000
75,000
500
180,520
5,020
100,000
75,000
500
180,520
69
11,559,667
$15,167,971
Federal Flow-Down
Univ. of Rochester
Univ. of South Carolina
Foundation/Other Non-Profit
American Academy of Otolaryngic Allergy
Lupus Research Institute
Melanoma Research Alliance
Sigma Xi
Grand Totals:
5
May 2014
Medical University of South Carolina
Printed: Jun 12, 2014
AWARD ACTIVITY
LISTED BY COLLEGE AND DEPARTMENT
# Awards
Direct Costs
Total Costs
1
1
25,000
$ 25,000
25,000
$25,000
1
1
95,557
$ 95,557
142,858
$142,858
1
1
18
6
4
7
2
1
2
5
8
3
4
1
2
2
67
69
201,275
42,676
2,431,185
599,602
754,711
1,795,300
5,700
72,577
225,817
76,704
3,522,980
285,883
125,723
745,806
270,237
282,934
$ 11,439,110
$ 11,559,667
300,906
42,676
3,137,821
814,019
872,159
2,575,302
5,700
93,000
304,594
108,408
4,339,257
425,622
153,370
1,097,689
362,975
366,615
$15,000,113
$ 15,167,971
Administration
Library Science & Informatics
College of Dental Medicine
Oral Health Sciences
College of Medicine
Biochemistry & Molecular Biology
Cell & Molecular Pharmacology
Medicine
Microbiology & Immunology
Neurology
Neurosciences
Obstetrics & Gynecology
Ophthalmology
Otolaryngology
Pediatrics
Psychiatry & Behavioral Sciences
Public Health Sciences
Radiology
Regenerative Medicine & Cell Biology
Surgery
Urology
Grand Totals:
6
May 2014
Medical University of South Carolina
Printed: Jun 12, 2014
Administration
Library Science & Informatics
Rivers, D
Corp. Support - National Conference on Health Disparities
Multiple Sponsors
02/01/2007 - 12/31/2016
02/01/2007 - 12/31/2016
Conference (016935)
$25,000
0
$25,000
$95,557
47,301
$142,858
$201,275
99,631
$300,906
Role of EZH2 in Extracellular Hsp90 Mediated Prostate Cancer
Tumorigenesis
NIH/NCI
05/01/2014 - 04/30/2015
05/01/2013 - 04/30/2016
5F31CA177015-02 (017643)
$42,676
0
$42,676
A Phase Ib Open Label Study of the Safety and Tolerability of ME-344 Given
in Combination with Topotecan (Hycamtin) in Patients with Solid Tumors
SCRI Development Innovations, LLC
04/30/2014 - 04/29/2018
04/30/2014 - 04/29/2018
ME-344-002 (018314)
$163,031
48,009
$211,040
reMARQable: nMARQ Pulmonary Vein Isolation System for the Treatment of
Paroxysmal Atrial Fibrillation - IDE 120289
Biosense Webster, Inc.
05/27/2014 - 12/31/2018
05/27/2014 - 12/31/2018
reMARQable (018330)
$445,902
132,571
$578,473
A Rollover Protocol to Allow Continued Access to Tivozanib Hydrochloride
(AV 951) for Subjects Enrolled in Other Tivozanib Hydrochloride Protocols
AVEO Pharmaceuticals, Inc.
12/20/2012 - 12/19/2019
12/20/2012 - 12/19/2019
AV-951-09-901 (017435)
$1,084
271
$1,355
12/05/2013 - 10/31/2018
12/05/2013 - 10/31/2018
$37,507
18,566
$56,073
Multicenter, Randomized, Active-Controlled Efficacy and Safety Study
Comparing Extended Duration Betrixaban With Standard of Care Enoxaparin
for the Prevention of Venous Thromboembolism in Acute Medic
Portola Pharmaceuticals, Inc.
03/28/2014 - 09/01/2015
03/28/2014 - 09/01/2015
11-019 (018291)
$48,191
14,157
$62,348
Identification of PIM Kinase Substrates in Sensitive DLBCL, Myeloma and
Prostate Cancer Cells by Mass Spectrometry
Astrazeneca
04/28/2014 - 04/27/2015
04/28/2014 - 04/27/2015
(018309)
$40,134
19,866
$60,000
College of Dental Medicine
Oral Health Sciences
Kirkwood, K
Integrating Biomechanics and Cell Biology to Understand TMJ Pathology
Clemson Univ.
03/01/2014 - 02/28/2015
03/06/2012 - 02/28/2015
R01DE021134/1602-209-2008855 (016962)
College of Medicine
Biochemistry & Molecular Biology
Heise, T
Screen for Inhibitors of La-Dependent IRES-Mediated Translation in Cancer
Cells
NIH/NCI
05/01/2014 - 04/30/2015
05/03/2013 - 04/30/2016
5R01CA172567-02 (017739)
Cell & Molecular Pharmacology
Nolan, K
Medicine
Britten, C
Cuoco, F
Drabkin, H
Gilkeson, G
Greenberg, C
Kraft, A
New Target Identification in Lupus
Berg, LLC
(018306)
7
May 2014
Medical University of South Carolina
Printed: Jun 12, 2014
College of Medicine
Medicine
Mims, A
Oates, J
Oates, J
Powers, E
Ramos, P
Shirai, K
Shirai, K
Stuart, R
Stuart, R
Tanner, N
Van Bakel, A
A Phase 2 Open-Label Study of the Efficacy of ABT-199 (GDC-0199) in
Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia
Harboring the 17p Deletion
INC Research, Inc.
05/20/2014 - 07/31/2014
05/20/2014 - 07/31/2014
M13-982 (018329)
$6,438
1,932
$8,370
A Phase II, Multi-Center, Randomized, Double-Blind, Placebo-Controlled,
Multi-dose, 24-week study to Evaluate the Efficacy and Safety of Atacicept in
Subjects with SLE
Quintiles Pacific, Inc.
05/07/2014 - 05/06/2017
05/07/2014 - 05/06/2017
EMR700461-023 (018322)
$102,587
29,801
$132,388
Identification of Dysregulated Pathways in SLE
Genentech, Inc.
(018297)
03/28/2014 - 03/27/2016
03/28/2014 - 03/27/2016
$61,695
14,330
$76,025
Lipid Rich Plaque (LRP) Outcomes Study
InfraReDx, Inc.
LRP Pcl# CL0116 (018317)
04/29/2014 - 12/31/2018
04/29/2014 - 12/31/2018
$501,885
149,365
$651,250
DNA Methylation Biomarkers of Scleroderma-Associated Interstitial Lung
Disease
NIH/NIAMS
05/01/2014 - 04/30/2015
05/01/2014 - 04/30/2017
1R03AR065801-01 (018294)
$50,000
24,750
$74,750
A Phase Ib Dose Escalation/Randomized Phase II, Multicenter, Open-Label
Study Of BYL719 In Combination With Cetuximab In Patients With Recurrent
Or Metastatic Head and Neck Squamous Cell Carcinoma
Novartis Corp.
05/16/2014 - 05/15/2016
05/16/2014 - 05/15/2016
BYL719X2104 (018319)
$181,777
53,183
$234,960
An Open-Label, Multi-center, Expanded Treatment Protocol (ETP) Of Oral
LDK378 In Adult Patients With Non-Small Cell Lung Cancer (NSCLC)
Characterized By ALK(+) Rearrangements In Patients Previously
Novartis Corp.
02/11/2014 - 06/30/2016
02/11/2014 - 06/30/2016
CLDK378A2402 (018298)
$134,104
37,696
$171,800
A Phase 1/2 Open-Label, Dose Escalation Study Investigating the
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP2215
in Patients with Relapsed or Refractory Acute Myeloid Leukemia
Astellas Pharma US, Inc.
04/07/2014 - 04/06/2017
04/07/2014 - 04/06/2017
2215-CL-0101 (018302)
$116,812
34,144
$150,956
Phase III, Multi-Center, Randomized Trial of CPS-351 Liposome Injection vs
Cytarabine and Daunorubicin in Patients 60-75 Years of Age
Celator Pharmaceuticals, Inc.
12/31/2012 - 12/30/2017
12/31/2012 - 12/30/2017
CLTR0310-301 (017414)
$94,858
23,714
$118,572
A Multi-Center Trial Comparing Standard 22-Gauge and 22-Gauge Procor
Needles for Endobronchial Ultrasound
Cook, Inc.
04/29/2014 - 04/28/2016
04/29/2014 - 04/28/2016
Cook Medical (018295)
$283,315
57,095
$340,410
Effect of Everolimus Immunotherapy on Anti-HLA Antibody Mediated
Activation of Endothelial Cells. A Retrospective Mechanistic Substudy of the
Novartis Sponsored Trial
Univ. of California, Los Angeles
10/21/2011 - 12/31/2014
10/21/2011 - 12/31/2014
1625-P-PC853 RAD Substudy (017633)
$462
115
$577
8
May 2014
Medical University of South Carolina
Printed: Jun 12, 2014
College of Medicine
Medicine
Whelan, T
Idiopathic Pulmonary Fibrosis Prospective Outcomes Registry (IPF_PRO)
Duke Univ.
05/01/2014 - 03/31/2019
05/01/2014 - 03/31/2019
IPF_PRO (018296)
$161,403
47,071
$208,474
Costimulatory Mechanisms of Antitumor Th17 Cell Immunity
NIH/NCI
05/01/2014 - 04/30/2015
07/01/2013 - 04/30/2018
5R01CA175061-02 (017785)
$201,275
99,632
$300,907
Management of the Nuclear Advisory Committee (NEAC)
SCUREF
03/03/2011 - 02/09/2016
03/03/2011 - 02/09/2016
DE-NE0000393/DENE005 (016374)
$80,105
10,723
$90,828
Chemotherapy Necessitates Increased Immune Control of Chronic HHVs: A
Cause of Persistent Inflammation Enabling Protracted Fatigue in Breast
Cancer Survivors
DOD
05/01/2014 - 04/30/2015
09/15/2011 - 04/30/2015
W81XWH-11-1-0704-P00001 (016957)
$86,760
38,988
$125,748
Antigen Specific Suppression of Autoimmunity in Lupus
Lupus Research Institute
08/15/2011 - 02/28/2014
08/15/2011 - 02/28/2014
(017596)
$100,000
0
$100,000
Alloreactive Regulatory T Cells Control GVHD and Maintain GVL Effect
NIH/NCI
07/01/2013 - 06/30/2014
07/01/2013 - 06/30/2016
7R01CA118116-06 (017870)
$80,806
39,999
$120,805
Th1/Th17 Cell Differentiation in GVHD and GVL
NIH/NCI
7R01CA143812-04 (017744)
06/14/2013 - 10/31/2014
06/01/2010 - 10/31/2014
$50,656
25,075
$75,731
Tailored Hospital-Based Risk Reduction to Impede Vascular Events after
Stroke
NIH/NINDS
05/01/2014 - 04/30/2015
09/01/2012 - 04/30/2017
5U01NS079179-04 (017411)
$444,657
64,442
$509,099
An Open-Label, Long-Gterm Safety Study of SD-809 (Dutetrabenazine) For
the Treatment of Moderate to Severe Tardive Dyskinesia - Protocol
Number:SD-809-C-20
INNO Clinical Outcomes, LLC
05/14/2014 - 05/31/2016
05/14/2014 - 05/31/2016
SD-809-C-18 (018312)
$137,735
39,220
$176,955
Characterization of Intracranial Atherosclerotic Stenosis Using HR MRI
NIH/NINDS
05/01/2014 - 04/30/2015
05/01/2011 - 04/30/2016
5K23NS069668-04 (016700)
$172,319
13,786
$186,105
Cortical Stimulation to Enhance Motor Recovery Following Traumatic Brain
Injury
NIH/NINDS
05/01/2014 - 04/30/2015
05/01/2011 - 04/30/2016
5R01NS065866-05 (016421)
$166,042
65,372
$231,414
Role of Locus Coeruleus in Response Inhibition
NIH/NIMH
5R01MH092868-04 (016208)
$225,000
106,875
$331,875
Microbiology & Immunology
Paulos, C
Schmidt, M
Thaxton, J
Vasu, C
Yu, X
Yu, X
Neurology
Ovbiagele, B
Revuelta, G
Turan, T
Neurosciences
Adkins, D
Aston-Jones, G
9
05/01/2014 - 04/30/2015
07/22/2011 - 04/30/2016
May 2014
Medical University of South Carolina
Printed: Jun 12, 2014
College of Medicine
Neurosciences
Gipson, C
Kalivas, P
Mulholland, P
Reichel, C
Sambamurti, K
Spencer, S
Contributions of Glial Glutamate Transport and NMDA Receptors in Nicotine
Relapse
NIH/NIDA
05/15/2014 - 04/30/2015
05/15/2014 - 04/30/2016
1K99DA036569-01 (018305)
$121,346
9,708
$131,054
Neurobiology of Addiction Center
NIH/NIDA
5P50DA015369-12 (016624)
05/01/2014 - 04/30/2015
07/01/2002 - 04/30/2018
$872,665
425,156
$1,297,821
Stress and Ethanol Dependence: SK Channels and Glutamate
NIH/NIAAA
02/01/2014 - 01/31/2015
02/10/2012 - 01/31/2017
5U01AA020930-03 (016329)
$8,717
4,141
$12,858
Corticostriatal Neuroplasticity and Cognition in Methamphetamine Addiction
NIH/NIDA
06/01/2014 - 05/31/2015
09/15/2012 - 05/31/2017
5R01DA033049-03 (017154)
$225,000
106,875
$331,875
Understanding the Neuroprotective Activities of Posiphen
NIH/NIA
05/01/2014 - 04/30/2015
07/15/2013 - 04/30/2015
5R21AG046200-02 (017826)
$125,000
61,875
$186,875
Role of Alpha2delta-1 in Cocaine Relapse and Gabapentin Mechanisms of
Action
NIH/NIDA
05/01/2014 - 04/30/2015
05/01/2014 - 04/30/2016
1F32DA037722-01 (018263)
$51,530
0
$51,530
Lipidomic Analysis of Eicosanoid Signaling in Inflammation and Endometrial
Cancer
Sigma Xi
03/01/2014 - 02/28/2015
03/01/2014 - 02/28/2015
(018300)
$500
0
$500
Summer Undergraduate Research Program in Oceans and Human Health
SC Sea Grant Consortium
05/26/2014 - 09/01/2014
05/29/2012 - 09/01/2014
NA10OAR4170073/M11Z (017065)
$5,200
0
$5,200
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety &
Efficacy of the KXL System w/ VibeX (Riboflavin Ophthalmic Solution) for
Corneal Collagen Cross-Linking in Eyes w/ Kerataconus
Avedro Inc.
05/15/2014 - 05/14/2019
05/15/2014 - 05/14/2019
KXL-001 (018326)
$72,577
20,423
$93,000
05/01/2014 - 04/30/2015
05/01/2012 - 04/30/2017
$220,797
78,777
$299,574
Relationship Between Sinonasal Mucosal Remodeling and Disease Severity
in Atopic and Non-Atopic CRS
American Academy of Otolaryngic Allergy
05/01/2014 - 07/31/2014
05/01/2014 - 07/31/2014
(018282)
$5,020
0
$5,020
NERI/NIH Site Service Agreements
New England Research Institutes
U01HL68270 (017600)
$1,234
346
$1,580
Obstetrics & Gynecology
Cantu, T
Guillette, L
Ophthalmology
Waring, G
Otolaryngology
Eckert, M
Oconnell, B
Methods for Retrospective Multi-Site Research
NIH/NICHD
5R01HD069374-03 (016634)
Pediatrics
Atz, A
03/04/2014 - 06/30/2016
01/28/2013 - 06/30/2016
10
May 2014
Medical University of South Carolina
Printed: Jun 12, 2014
College of Medicine
Pediatrics
Kraveka, J
Lee, K
Ryan, R
A Phase III Randomized Trial for Newly Diagnosed High Risk B-precursor
Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine in the Very High
Risk Stratum
Childrens Hosp. of Philadelphia
05/28/2014 - 05/30/2016
05/28/2014 - 05/30/2016
AALL1131 (018332)
$29,615
8,885
$38,500
Elucidating the Phosphatase-Independent Roles of PTPN11 in the Heart
Beth Israel Deaconess Med. Ctr.
04/01/2014 - 03/31/2015
06/01/2013 - 03/31/2017
R01HL114775/01026527 (017994)
$34,638
17,145
$51,783
Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic
Preemies
Univ. of Rochester
05/01/2014 - 04/30/2015
07/01/2011 - 04/30/2015
U01HL101813/416385 (016775)
$11,217
5,328
$16,545
05/01/2014 - 04/30/2015
05/26/2006 - 04/30/2016
$132,490
10,599
$143,090
Ethanol Dependence and Stress Effects on Ethanol Drinking: Role of CRF
NIH/NIAAA
02/01/2014 - 01/31/2015
03/01/2003 - 01/31/2017
5U01AA014095-12 (016391)
$13,930
6,617
$20,547
South Carolina Clinical and Translational Research Institute
NIH/NCATS
05/15/2014 - 03/31/2015
07/14/2009 - 03/31/2015
3UL1TR000062-05S1 (016836)
$2,364,857
523,955
$2,888,812
05/01/2014 - 04/30/2015
05/26/2006 - 04/30/2016
$132,490
10,599
$143,090
The Effect of Point-of-Sale Tobacco Marketing on Smoking Cessation
Among Adults
Univ. of Nebraska
03/01/2014 - 02/28/2015
03/07/2013 - 02/28/2015
R01CA166156/34-5450-2003-001 (017872)
$8,200
4,059
$12,259
Building Evidence for Effective and Sustainable Cigarette Warning Label
Policy
Univ. of South Carolina
05/01/2014 - 04/30/2015
07/01/2012 - 04/30/2015
R01CA167067/11590-FA59 (017180)
$7,099
3,372
$10,471
Trans-Cranial Direct Current Stimulation to Treat Aphasia: Phase II Trial
Univ. of South Carolina
04/01/2014 - 03/31/2015
04/01/2012 - 03/31/2017
U01DC011739/14-2655 (016746)
$251,384
119,408
$370,792
02/01/2014 - 01/31/2015
02/10/2012 - 01/31/2017
$18,840
8,949
$27,789
Implementation of Prolonged Exposure in the Army: Is Consultation
Necessary for Effective Dissemination?
Univ. of Pennsylvania
10/01/2013 - 09/30/2014
07/01/2013 - 12/31/2014
W81XWH-12-2-0116/560165 (018236)
$102,330
25,903
$128,233
TF-CBT for Adjudicated Youth in Residential Treatment
Allegheny-Singer Research Inst.
12/01/2013 - 11/30/2014
07/15/2011 - 11/30/2014
R01MH095208/49243509MUSC (016597)
$22,073
10,484
$32,557
Psychiatry & Behavioral Sciences
Back, S (50% credit)
Becker, H
Brady, K
Brady, K (50% credit)
Cummings, K
Cummings, K
George, M
Lopez, M
Ruggiero, K
Saunders, B
Drug Abuse Research Training
NIH/NIDA
5R25DA020537-09 (016674)
Drug Abuse Research Training
NIH/NIDA
5R25DA020537-09 (016674)
Mouse Chronic Intermittent Ethanol (CIE) Core
NIH/NIAAA
5U01AA020929-03 (016319)
11
May 2014
Medical University of South Carolina
Printed: Jun 12, 2014
College of Medicine
Psychiatry & Behavioral Sciences
Sweat, M
Phase II RCT of Comprehensive Triage HIV Prevention: Tanzania
NIH/NIMH
05/01/2014 - 04/30/2015
07/19/2012 - 04/30/2015
5R01MH095869-03 (016905)
$469,286
92,332
$561,618
Prolonging Remission in Depressed Elderly (PRIDE)
Mt. Sinai School of Medicine
04/01/2014 - 03/31/2015
04/01/2014 - 03/31/2015
U01MH055495/0255-0106-4609 (018321)
$230,764
114,228
$344,992
Surveillance of Spatial Case Event Data in Cancer Studies
NIH/NCI
05/01/2014 - 04/30/2015
05/01/2014 - 04/30/2016
1R03CA179665-01A1 (018293)
$50,000
23,079
$73,079
$5,119
2,432
$7,551
$400
100
$500
04/01/2014 - 12/30/2014
04/01/2014 - 12/30/2014
$28,000
0
$28,000
Evaluation of the GORE VIABAHN BALLOON EXPANDABLE
ENDOPROSTHESIS (VIABAHN BX) for the Treatment of Occlusive Disease
in the Common and External Iliac Arteries
W.L. Gore and Associates, Inc.
04/29/2014 - 04/28/2019
04/29/2014 - 04/28/2019
BES 10-07 (018301)
$41,392
11,518
$52,910
ENDOvascular Interventions with AngioMAX: The ENDOMAX Trial
The Medicines Co.
04/29/2014 - 04/30/2015
04/29/2014 - 04/30/2015
MDCO-BIV-12-03 (018292)
$55,931
16,029
$71,960
SC COBRE for Developmentally Based Cardiovascular Diseases
NIH/NIGMS
05/01/2014 - 04/30/2015
08/01/2012 - 04/30/2017
5P30GM103342-03 (017096)
$745,806
351,883
$1,097,689
Oxidative Stress and AICD in Memory T Cell Persistence
NIH/NCI
05/01/2014 - 04/30/2015
06/02/2010 - 04/30/2015
5R01CA138930-05 (016662)
$195,237
92,738
$287,975
Augmenting Anti-Tumor Immunity by Modulating IL-2/IL-15 Receptor Binding
Melanoma Research Alliance
05/01/2014 - 04/30/2015
05/01/2013 - 04/30/2016
262885 (017693)
$75,000
0
$75,000
Public Health Sciences
Knapp, R
Lawson, A
Ramakrishnan, V
Insights on Selected Procoagulation and Outcomes in Stroke Trial (I-SPOT)
Temple University
02/01/2014 - 01/31/2015
02/01/2013 - 01/31/2018
5U01NS079077-02/361009-05430-02/PO173661
(017609)
Radiology
Guimaraes, M
Schoepf, U
Schonholz, C
Schonholz, C
GORE VIABAHN Endoprosthesis versus Percutaneous Transluminal
Angioplasty (PTA) to Revise Arteriovenous Grafts at the Venous Anastomosi
s in Hemodialysis Patients GORE REVISE Study
W.L. Gore and Associates, Inc.
04/21/2014 - 06/30/2015
04/21/2014 - 06/30/2015
AVR 06-01 (018290)
Siemens Fellowship
Siemens Medical Solutions USA
(018304)
Regenerative Medicine & Cell Biology
Markwald, R
Surgery
Mehrotra, S
Rubinstein, M
12
May 2014
Medical University of South Carolina
Printed: Jun 12, 2014
College of Medicine
Urology
Prasad, S
Rovner, E
A Prospective, Single-blind, Randomized, Phase III Study to Evaluate the
Safety and Efficacy of Fibrin Sealant Grifols (FS Grifols) as an Adjunct to
Hemostasis During Soft Tissue Open Surgeries
PRA International
04/30/2014 - 12/31/2017
04/30/2014 - 12/31/2017
IG1103 (018299)
$106,996
31,799
$138,795
A Phase 2 Multicenter, Randomized, Double-Blinded, Placebo-Controlled
Study Evaluating Safety, Tolerability and Efficacy of LiRIS 400 mg in Women
with Interstitial Cystitis
Taris Biomedical, Inc.
05/08/2014 - 10/31/2016
05/08/2014 - 10/31/2016
TAR-100-202 (018310)
$175,938
51,882
$227,820
13
May 2014

Download Report